May Chin Yong1, Xuelian Jamie Zhou, Soo Chin Lee. 1. Department of Haematology-Oncology, National University Hospital Singapore, 5 Lower Kent Ridge Road, Singapore 119074, Republic of Singapore.
Abstract
OBJECTIVES: Cancer genetics clinics have been established in many major oncology centers worldwide in recent years. For such specialized clinics to fulfill their function, primary care physicians need to identify high-risk patients for referral. METHODS: We conducted a survey to evaluate the level of awareness of breast cancer risk factors and hereditary breast cancer among health care providers and patients. RESULTS: 284 health care professionals, 221 medical students, 104 breast cancer patients and 177 cancer-free women participated in the study. Less than half of the patients with breast cancer were aware of their risk for another breast cancer or of the increased breast cancer risk of their sisters and daughters. Less than one quarter of the health care professionals and medical students knew the importance of paternal family history in the evaluation for hereditary breast cancer. Only about half of the health care professionals and medical students and less than one third of the breast cancer patients and cancer-free women knew about genetic testing and prophylactic mastectomy as options for women at risk for hereditary breast cancer. CONCLUSIONS: Health care providers and medical students lack basic genetic knowledge and are not aware of emerging diagnostic and preventive options for hereditary breast cancer. Inclusion of cancer genetics in the continuing medical education of health care providers is important to promote such awareness. Copyright 2003 S. Karger AG, Basel
OBJECTIVES:Cancer genetics clinics have been established in many major oncology centers worldwide in recent years. For such specialized clinics to fulfill their function, primary care physicians need to identify high-risk patients for referral. METHODS: We conducted a survey to evaluate the level of awareness of breast cancer risk factors and hereditary breast cancer among health care providers and patients. RESULTS: 284 health care professionals, 221 medical students, 104 breast cancerpatients and 177 cancer-free women participated in the study. Less than half of the patients with breast cancer were aware of their risk for another breast cancer or of the increased breast cancer risk of their sisters and daughters. Less than one quarter of the health care professionals and medical students knew the importance of paternal family history in the evaluation for hereditary breast cancer. Only about half of the health care professionals and medical students and less than one third of the breast cancerpatients and cancer-free women knew about genetic testing and prophylactic mastectomy as options for women at risk for hereditary breast cancer. CONCLUSIONS: Health care providers and medical students lack basic genetic knowledge and are not aware of emerging diagnostic and preventive options for hereditary breast cancer. Inclusion of cancer genetics in the continuing medical education of health care providers is important to promote such awareness. Copyright 2003 S. Karger AG, Basel
Authors: Kimberly M Kelly; Margaret M Love; Kevin A Pearce; Kyle Porter; Mary A Barron; Michael Andrykowski Journal: J Rural Health Date: 2009 Impact factor: 4.333
Authors: Jeanna M McCuaig; Celia M T Greenwood; Cheryl Shuman; David Chitayat; K Joan Murphy; Barry Rosen; Susan Randall Armel Journal: J Genet Couns Date: 2011-04-19 Impact factor: 2.537
Authors: Wylie Burke; Julie Culver; Linda Pinsky; Sarah Hall; Susan E Reynolds; Yutaka Yasui; Nancy Press Journal: Am J Med Genet A Date: 2009-03 Impact factor: 2.802
Authors: Nicky Dekker; Eleonora B L van Dorst; Rob B van der Luijt; Marielle E van Gijn; Marc van Tuil; Johan A Offerhaus; Margreet G E M Ausems Journal: J Genet Couns Date: 2012-11-30 Impact factor: 2.537
Authors: Wendy S Rubinstein; Suzanne M O'neill; Nan Rothrock; Erin J Starzyk; Jennifer L Beaumont; Louise S Acheson; Catharine Wang; Robert Gramling; James M Galliher; Mack T Ruffin Journal: Genet Med Date: 2011-01 Impact factor: 8.822